Lenalidomide plus Dexamethasone (RD) vs Melphalan-Lenalidomide-Prednisone (MPR) or Cyclophosphamide-Prednisone-Lenalidomide (CPR) in elderly community-based newly diagnosed multiple myeloma patients: efficacy and safety results from a Phase 3 trial